Drug Rehab Placement in Los Angeles

Substances Covered by Placement

Placement advisors at New Beginnings work with licensed inpatient programs across Los Angeles that treat opioid use disorder (fentanyl, heroin, prescription opioids), stimulant use disorder (methamphetamine, cocaine), sedative/hypnotic use disorder (benzodiazepines like Xanax, Ativan, Klonopin), and polysubstance use. Many callers present with more than one substance — polysubstance combinations involving fentanyl and methamphetamine are increasingly common in LA — and the referred programs are equipped to treat them together.

Why Medical Detox Matters for Drug Rehab

Withdrawal risk and protocol vary by substance. Benzodiazepines and high-dose opioids have medically significant withdrawal that benefits from supervised tapering. Opioid withdrawal itself is rarely life-threatening but is miserable enough that most attempts without medical support fail — MAT with buprenorphine or methadone transforms outcomes and is the clinical standard. Stimulant withdrawal is psychological rather than physical but still benefits from the structured environment of a residential setting. The licensed programs we refer to deliver substance-specific detox protocols.

The Fentanyl Story in Los Angeles

Fentanyl overdose deaths in LA County surged from 109 deaths in 2016 to more than 2,000 in 2023 — a roughly 1,700% increase. In 2024 that trend reversed for the first time. The 37% single-year decline in fentanyl deaths came from a combined public-health push: expanded naloxone distribution (now over the counter in every California pharmacy and available via CalRx for $24 per two-pack), fentanyl test strip distribution (free via DHCS), a 500% increase in county harm-reduction funding, and a 275% increase in treatment funding. The inpatient treatment side of that story — medically supervised detox followed by residential care — is exactly what placement advisors at New Beginnings coordinate.

Methamphetamine Treatment in Los Angeles

LA County methamphetamine-related overdose deaths fell 20% in 2024 after years of relative stability. Unlike opioids, there is no FDA-approved medication for methamphetamine use disorder — behavioral interventions (contingency management, CBT, the Matrix Model) are the clinical foundation. Residential inpatient is often the right level of care because of the severity of early-abstinence symptoms (depression, anhedonia, cravings, sleep disruption) and because meth use frequently co-occurs with unstable housing that makes outpatient less viable.

What Does Inpatient Drug Rehab Cost in Los Angeles?

Without insurance, standard 30-day inpatient drug rehab in LA runs $6,000 to $20,000; luxury programs $30,000+. With a commercial PPO subject to California SB 855, out-of-pocket typically drops to $3,000–$9,000 for 30 days. Medical detox is usually bundled into the overall program cost. Placement advisors verify specific benefits by phone in about 15 minutes.

Does Insurance Cover Drug Rehab in California?

Commercial PPO plans regulated in California are required to cover medically necessary drug rehab under SB 855. The law treats opioid use disorder, stimulant use disorder, and sedative use disorder equivalently — all are substance use disorders as defined by DSM-5 and therefore covered at the same level as any other medical condition. 2025 enforcement rules add additional teeth.